Pharmacologic management of aggression and violence.
The author discusses the differential diagnosis of violent and aggressive behavior, traditional and alternative treatments and OBRA-90 legislation.
Department of Internal Medicine, University of Iowa Hospitals and Clinics.
T
T
Anfinson
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000374:Aggression / Q000187:drug effects*; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000627:therapeutic use; D002220:Carbamazepine / Q000627:therapeutic use; D000075202:Contraindications; D003693:Delirium / Q000188:drug therapy; D003937:Diagnosis, Differential; D006801:Humans; D008094:Lithium / Q000627:therapeutic use; D014196:Trazodone / Q000627:therapeutic use; D014754:Violence
D000319:Adrenergic beta-Antagonists; D014150:Antipsychotic Agents; D001569:Benzodiazepines; D002220:Carbamazepine; D008094:Lithium; D014196:Trazodone